Literature DB >> 22323880

Clinical characteristics of polypoidal choroidal vasculopathy associated with chronic central serous chorioretionopathy.

Han Sang Park1, In Taek Kim.   

Abstract

PURPOSE: To investigate the clinical characteristics of polypoidal choroidal vasculopathy (PCV) associated with chronic central serous chorioretinopathy (CSC).
METHODS: We retrospectively reviewed the medical records of 246 PCV patients (283 eyes) between July 2004 and August 2009 and investigated the clinical characteristics of the PCV patients who had specific fundus findings of chronic CSC.
RESULTS: Among PCV patients, 13 eyes (4.6%) of 13 PCV patients (5.3%) had fundus findings of chronic CSC. All of the PCV lesions had a solitary polyp located outside the atrophic retina, predominantly in the macular area (84.6%), most showed an exudative pattern (69.2%) and there were a few that showed a hemorrhagic pattern (30.8%). All of the lesions were smaller than 1 disc diameter. Most of the PCV lesions (76.9%) were cured with less than two treatments in a short period of 6.4 ± 1.9 months; however, visual acuity deteriorated (61.5%) or was not changed (30.8%) in most of the cases.
CONCLUSIONS: The PCV associated with chronic CSC had several clinical features such as a small exudative retinal lesion with a solitary polyp and frequent involvement of the macular area. Even though there was poor visual outcome due to the atrophic change, all of the PCV lesions were easily resolved in a short period with a simple treatment course and no recurrence.

Entities:  

Keywords:  Chronic central serous chorioretinopathy; Indocyanine green angiography; Polypoidal choroidal vasculopathy

Mesh:

Substances:

Year:  2012        PMID: 22323880      PMCID: PMC3268163          DOI: 10.3341/kjo.2012.26.1.15

Source DB:  PubMed          Journal:  Korean J Ophthalmol        ISSN: 1011-8942


  24 in total

1.  Indocyanine green angiography of central serous chorioretinopathy.

Authors:  K Hayashi; Y Hasegawa; T Tokoro
Journal:  Int Ophthalmol       Date:  1986-04       Impact factor: 2.031

2.  Indocyanine green videoangiography of older patients with central serous chorioretinopathy.

Authors:  R F Spaide; L Hall; A Haas; L Campeas; L A Yannuzzi; Y L Fisher; D R Guyer; J S Slakter; J A Sorenson; D A Orlock
Journal:  Retina       Date:  1996       Impact factor: 4.256

3.  Indocyanine green angiography in central serous chorioretinopathy. ICG angiography in CSC.

Authors:  U Menchini; G Virgili; P Lanzetta; E Ferrari
Journal:  Int Ophthalmol       Date:  1997       Impact factor: 2.031

4.  Central serous chorioretinopathy in younger and older adults.

Authors:  R F Spaide; L Campeas; A Haas; L A Yannuzzi; Y L Fisher; D R Guyer; J S Slakter; J A Sorenson; D A Orlock
Journal:  Ophthalmology       Date:  1996-12       Impact factor: 12.079

5.  Indocyanine green angiographic findings in central serous chorioretinopathy.

Authors:  F C Piccolino; L Borgia; E Zinicola; M Zingirian
Journal:  Eye (Lond)       Date:  1995       Impact factor: 3.775

6.  Central serous chorioretinopathy and indocyanine green angiography.

Authors:  F C Piccolino; L Borgia
Journal:  Retina       Date:  1994       Impact factor: 4.256

7.  Digital indocyanine green videoangiography of central serous chorioretinopathy.

Authors:  D R Guyer; L A Yannuzzi; J S Slakter; J A Sorenson; A Ho; D Orlock
Journal:  Arch Ophthalmol       Date:  1994-08

8.  Choroidal capillary and venous congestion in central serous chorioretinopathy.

Authors:  C Prünte; J Flammer
Journal:  Am J Ophthalmol       Date:  1996-01       Impact factor: 5.258

9.  Long-term follow-up of central serous retinopathy in 150 patients.

Authors:  J Castro-Correia; M F Coutinho; V Rosas; J Maia
Journal:  Doc Ophthalmol       Date:  1992       Impact factor: 2.379

10.  Laser treatment of diffuse retinal pigment epitheliopathy.

Authors:  L A Yannuzzi; J S Slakter; S R Kaufman; K Gupta
Journal:  Eur J Ophthalmol       Date:  1992 Jul-Sep       Impact factor: 1.922

View more
  10 in total

Review 1.  Idiopathic polypoidal choroidal vasculopathy: a review of literature with clinical update on current management practices.

Authors:  Yamini Sahu; Niharika Chaudhary; Mukesh Joshi; Aastha Gandhi
Journal:  Int Ophthalmol       Date:  2020-10-20       Impact factor: 2.031

2.  Polypoidal choroidal vasculopathy and history of central serous chorioretinopathy.

Authors:  T Toyama; K Ohtomo; Y Noda; T Ueta
Journal:  Eye (Lond)       Date:  2014-06-13       Impact factor: 3.775

3.  Subfoveal choroidal thickness as a predictor of treatment response to anti-vascular endothelial growth factor therapy for polypoidal choroidal vasculopathy.

Authors:  Hyesun Kim; Sung Chul Lee; Kye Yoon Kwon; Ji Hwan Lee; Hyoung Jun Koh; Suk Ho Byeon; Sung Soo Kim; Min Kim; Christopher Seungkyu Lee
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-12-01       Impact factor: 3.117

4.  Unilateral decreased vision in a middle-aged man.

Authors:  Alireza Ramezani; Alireza Lashay; Ahmad M Mansour; Touka Banaee
Journal:  J Ophthalmic Vis Res       Date:  2013-01

Review 5.  Polypoidal Choroidal Vasculopathy in Asians.

Authors:  Chee Wai Wong; Tien Y Wong; Chui Ming Gemmy Cheung
Journal:  J Clin Med       Date:  2015-04-24       Impact factor: 4.241

6.  Clinical characteristics and long-term visual outcome of severe phenotypes of chronic central serous chorioretinopathy.

Authors:  Danial Mohabati; Thomas J van Rijssen; Elon Hc van Dijk; Gregorius Pm Luyten; Tom O Missotten; Carel B Hoyng; Suzanne Yzer; Camiel Jf Boon
Journal:  Clin Ophthalmol       Date:  2018-06-07

7.  Cuticular drusen associated with aneurysmal type 1 neovascularization (polypoidal choroidal vasculopathy).

Authors:  Serena Fragiotta; Talia R Kaden; K Bailey Freund
Journal:  Int J Retina Vitreous       Date:  2018-12-05

Review 8.  Polypoidal choroidal vasculopathy: An update on current management and review of literature.

Authors:  Amit Harishchandra Palkar; Vikas Khetan
Journal:  Taiwan J Ophthalmol       Date:  2019 Apr-Jun

9.  Response to comment on: Validating the pachychoroid disease spectrum using multimodal imaging.

Authors:  Guruprasad Ayachit; Apoorva Ayachit; Harsha Nadgir; Shrinivas Joshi
Journal:  Indian J Ophthalmol       Date:  2019-02       Impact factor: 1.848

Review 10.  Central serous chorioretinopathy: Current update on pathophysiology and multimodal imaging.

Authors:  George Joseph Manayath; Ratnesh Ranjan; Vanee Sheth Shah; Smita S Karandikar; Veerappan R Saravanan; Venkatapathy Narendran
Journal:  Oman J Ophthalmol       Date:  2018 May-Aug
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.